INTRODUCTION
============

Tuberculosis (TB), an infectious disease caused by *Mycobacterium tuberculosis (M. tb)*, is a dreadful disease with high rate of morbidity and mortality across the globe \[[@R1]\]. *M. tb* infects nearly one-third of the world's population, out of which only 5-10% develop actual TB during their life time \[[@R2]\]. Previous studies reported that among all types of TB cases, 20% cases belong to extrapulmonary tuberculosis (EPTB) \[[@R3]\]. A key role played by the host genetic factors in risk of developing TB has been suggested by earlier studies \[[@R4]-[@R7]\]. Recently, genome-wide association studies (GWAS) demonstrate that host genetics factors are strongly linked with TB development \[[@R8]\]. Earlier reports showed that P2X7 receptor plays a major role in initiation of activity against mycobacteria and ATP works significantly in triggering of this activity along with human macrophages \[[@R9]\]. The gene for *P2X7* encoding the *P2X7* receptor is located on chromosome 12q24 of the human genome \[[@R10]\]. The P2X7 receptor is highly expressed by the cells of haemopoietic lineage and can trigger cell death, kill infectious organisms, and regulate inflammatory responses \[[@R11]\]. The involvement of P2X7 receptor in above mentioned pathways suggests that it plays a role of a major regulator of inflammation. The ATP treatment of macrophages infected with mycobacteria induces apoptosis and death of both the host cell and the internalized bacilli. The process is mediated *via* the P2X7 pathway \[[@R12]\]. The use of *P2X7* antagonist has been shown to inhibit the ATP induced apoptosis and bacterial killing in infected macrophages in another study \[[@R13]\].

Many single nucleotide polymorphisms (SNPs) of *P2X7* gene are reported in the literature indicating high polymorphic nature of this gene in humans \[[@R14]\]. A common SNP altering the function of the *P2X7* receptor is A1513C, located in the carboxy terminal tail encoding region of the *P2X7* gene \[[@R15], [@R16]\], which could affect an individual susceptibility to EPTB.

Keeping the biological significance of this genetic variant in view, the association of *P2X7* A1513C polymorphism with the susceptibility of TB has been widely studied. Previously, it has been reported that the pathophysiology of EPTB is differ from other types of TB \[[@R17]\]. So, it is important to examine the genetic variants of *P2X7* receptor gene specifically associated with EPTB. Till now, several research studies have been done to assess the possible association between *P2X7* A1513C genetic polymorphism and the development of EPTB in different populations but their findings are either contradictory or inconclusive \[[@R18]-[@R25]\]. Therefore, data from various case-control studies were pooled and meta-analysis was performed to derive a more precise conclusion regarding the relationship between the overall effect of *P2X7* 1513 A\>C genetic variant and the risk of developing EPTB. A meta-analysis is a potent method for evaluating cumulative data from different research studies to overcome the problem of small sample sizes and low statistical power \[[@R26]\], and has been successfully used for the pooling of the data for different case-control studies in relation with various polygenic diseases, e.g., cancer \[[@R27]\], tuberculosis \[[@R6], [@R7]\] etc. The schematic representation of the entire meta-analysis has been given as graphical abstract (Fig. **[1](#F1){ref-type="fig"}**).

MATERIALS AND METHODS
=====================

Identification and Eligibility of the Studies
---------------------------------------------

Pertinent studies were cautiously identified by comprehensive search of PubMed (Medline) and EMBASE web databases using the following key words: "*P2X7* gene AND (polymorphism OR variant OR mutation) AND (A1513C OR rs3751143) AND Extrapulmonary tuberculosis (EPTB)" to cover all the published research articles (last updated on June 2015). Research studies that express potential relevance for genetic association were weighed up by scrutinizing their titles and abstracts. All the studies matching with the above mentioned eligibility criteria were selected and included in the present meta-analysis.

Inclusion and Exclusion Criteria for the Studies
------------------------------------------------

In order to reduce heterogeneity and to facilitate the accuracy of the findings in the present meta-analysis, preset criteria were followed for study inclusion/ exclusion. The study inclusion criteria were: (i) evaluation of *P2X7* A1513C A\>C polymorphism and EPTB risk, (ii) use of case-control design, (iii) enrollment of pathologically confirmed EPTB patients and TB-free controls, (iv) availability of genotype frequency in cases as well as in controls, and (v) published in the English language. In case, if the case-control study was reported by more than one article using the same case series, study with highest number of subjects was selected. Studies reporting overlapping data, case-only studies and review articles were the leading reasons for exclusion of the studies.

Data Extraction and Quality Assessment
--------------------------------------

The methodological quality assessment and the data extraction for all the selected publications were independently abstracted by two independent investigators in duplicate using the standard protocol. The data accuracy was ascertained by using a data-collection form according to the preset inclusion criteria as stated in the above section. The difference of opinion, if any, on the items collected from the retrieved studies was discussed in detail to achieve a common consensus. The abstracted characters from the selected studies assimilated the first author's name, the publication year, the country of origin, sources of cases and controls and their numbers, genotype frequencies, and the study type.

Statistical Analysis
--------------------

The pooled odds ratios (ORs) and their respective 95% confidence intervals (CIs) were estimated to assess the relation between -1513 A\>C polymorphism and EPTB risk. Heterogeneity belief was investigated by the chi-square based Q-test \[[@R28]\]. The significance level (p-value) \> 0.05 for the Q-test indicated a lack of heterogeneity among all the selected studies. Fixed/ random effects models were used to pool ORs \[[@R29], [@R30]\]. Additionally, I^2^ statistics was used to measure the inter-study variability ranging between 0 to 100%, wherein, 0% indicates no observed heterogeneity and larger values indicate an increasing degree of heterogeneity \[[@R31]\]. The Hardy-Weinberg equilibrium (HWE) was calculated using the chi-square test in the control group. The funnel plot asymmetry was calculated by the Egger's linear regression test, which is a linear regression methodology to measure the funnel plot asymmetry on the natural logarithm scale of the OR. Student's t-test (p-value \<0.05 was maintained as a sign of statistically significant publication bias) was used to determine the significance of the intercept \[[@R32]\]. The entire statistical analysis for the current meta-analysis was executed with the help of comprehensive meta-analysis (CMA) Version 2 software program (Biostat, USA). The CMA V2 has many positive aspects in comparison to other meta-analysis software programs. A precise and comprehensive comparison of meta-analysis programs was performed for the selection of apt meta-analysis program using url. <http://meta-analysis.com/pages/comparisons.html>.

RESULTS
=======

Characteristics of the Selected Published Studies
-------------------------------------------------

The number of hits obtained by doing a literature search on PubMed (Medline) and EMBASE database was twenty eight. All the retrieved hits (articles) were checked by reading their titles, and abstracts, and the full texts for the possibly relevant publications. In addition, the articles were further scrutinized for their aptness for the present meta-analysis (Fig. **[2](#F2){ref-type="fig"}**: PRISMA Flow-diagram). Similarly, the reference lists of the retrieved publications were also screened for other possible apposite articles. The studies of *P2X7* polymorphism predicting survival and considering it as therapy response indicator were excluded straightaway. Research articles that report the levels of P2X7 mRNA or protein expression and also the review articles were disqualified. In order to derive a precise conclusion from this pooled analysis, a very stringent criterion was followed for searching the publication. Only case-control or cohort design studies with frequencies of all the three genotypes were included. After thorough analysis and following the stern inclusion and exclusion criteria, eight originally published studies representing the above mentioned possible association were found eligible and included in this study (Table **[1](#T1){ref-type="table"}**). The selection process (inclusion/ exclusion) of the studies for this meta-analysis is shown in a PRISMA flow-diagram in (Fig. **[2](#F2){ref-type="fig"}**). Information regarding distribution of genotypes, HWE p-values in the controls, and susceptibility to EPTB is provided in (Table **[2](#T2){ref-type="table"}**).

Evaluation of Publication Bias
------------------------------

Funnel plot and Egger's test were employed to test publication bias among the selected studies (Table **[3](#T3){ref-type="table"}**). The funnel plot remained symmetric for CC vs. AA, whereas CC vs. AA+AC showed absence of publication bias. Nevertheless, plots for C vs. A, AC vs. AA and CC+AC vs. AA were asymmetric (Table **[3](#T3){ref-type="table"}**). To adjust the publication bias, Trim-and-fill technique was used for these three genetic models (C vs. A, AC vs. AA and CC+AC vs. AA) in order to re-compute the effect size \[[@R33]\].

Test of Heterogeneity
---------------------

Q-test and I^2^ statistics were used to evaluate the inter- and intra-study variations and based upon the significance value different models were selected for this meta-analysis (Table **[3](#T3){ref-type="table"}**). We observed heterogeneity in all the genetic models, i.e., allele (C vs. A), heterozygous (AC vs. AA), homozygous (CC vs. AA), recessive (CC + AC vs. AA) and dominant (CC vs. AA+ AC), hence random effects model was applied.

Meta-analysis of P2X7 1513 A \> C Polymorphism and EPTB Susceptibility
----------------------------------------------------------------------

Cautious evaluation of all the data from eight selected studies was done and the data were pooled together which accumulated to 2237 controls and 594 EPTB cases. The random effects model was used to evaluate the overall association between the *P2X7* 1513 A\>C polymorphism and the risk of EPTB (Fig. **[3a](#F3a){ref-type="fig"}** and Fig. **[3b](#F3b){ref-type="fig"}**). Overall, four genetic models, allele (C vs. A: p = 0.011; OR = 1.677, 95% CI = 1.125-2.501), homozygous (CC vs. AA: p = 0.053; OR= 2.362, 95% CI = 0.991-5.632), heterozygous (AC vs. AA: p = 0.003; OR = 1.775, 95% CI = 1.209--2.607), dominant (CC + AC vs. AA: p = 0.005; OR= 1.890, 95% CI = 1.207--2.962) were found to be significantly associated with an increased risk of EPTB as compared to wild type genotype. Whereas, recessive (CC vs. AA+ AC: p = 0.099; OR= 1.814, 95% CI = 0.894--3.681) genetic model did not show any risk of EPTB.

Sensitivity Analysis
--------------------

To estimate the effect of each individual study on the pooled OR, one way sensitivity analysis was done where one single study was deleted serially each time. Omitting one

study at a time in the meta-analysis did not influence the pooled ORs that represents the robustness and credibility of the results obtained in the present meta-analysis (data not shown).

Subgroup Analysis
-----------------

In this present pooled analysis, we have stratified the studies of *P2X7* 1513 A\>C and EPTB risk for the subgroup analysis based upon the ethnicity to detect impact of this association among Asians and Caucasians. Four studies from Asian and five studies from Caucasian populations were included in this study.

Asian Population
----------------

In some of the genetic models, heterogeneity and publication bias were found in Asian ethnicity, so based on heterogeneity, random and fixed effect model were employed (Fig. **[4](#F4){ref-type="fig"}**). We found that homozygous genotype (CC vs. AA: p=0.053; OR=1.959, 95% CI=0.991-3.871) and heterozygous genotype (AC vs. AA: p = 0.009; OR= 1.584, 95% CI= 1.120-2.239) found significant increased risk of EPTB. Whereas, allele (C vs. A: p = 0.093; OR= 1.673, 95% CI= 0.917-3.052), dominant (CC + AC vs. AA: p = 0.075; OR= 1.975, 95% CI = 0.933--4.184) and recessive (CC vs. AA+ AC: p = 0.189; OR= 1.549, 95% CI = 0.806--2.976) genetic models did not show any risk of developing EPTB (Table **[4](#T4){ref-type="table"}**; Fig. **[4](#F4){ref-type="fig"}**).

Caucasian Population
--------------------

In Caucasian ethnicity, publication bias did not exist. We found heterogeneity in all the five genetic models, so random effect model was applied (Fig. **[5a](#F5a){ref-type="fig"}** and Fig. **[5b](#F5b){ref-type="fig"}**). Heterozygous genotype (AC vs. AA: p = 0.039; OR = 1.718, 95% CI = 1.027-2.875) and dominant (CC + AC vs. AA: p = 0.055; OR = 1.856, 95% CI = 0.988--3.487) showed increased risk of EPTB as compared to the wild type genotype. Other genotypic models, allele (C vs. A: p = 0.083; OR= 1.685, 95% CI = 0.935-3.036), homozygous (CC vs. AA: p = 0.198; OR= 2.325, 95% CI = 0.643--8.409) and recessive (CC vs. AA+ AC: p = 0.262; OR= 1.854, 95% CI = 0.630-5.456) failed to show any risk of developing EPTB (Table **[5](#T5){ref-type="table"}**; Fig. **[5a](#F5a){ref-type="fig"}** and Fig. **[5b](#F5b){ref-type="fig"}**).

DISCUSSION
==========

The presence of EPTB is generally determined by a combination of environmental and genetic factors. The precise mechanism conferring resistance against *M. tb* infection is still obscure, even though both innate and acquired immunity are known to play their part in eliminating this infection. However, involvement of various genes in *M. tb* susceptibility has been evident from the literature \[[@R34]\]. We also know that macrophages are the main cells allowing mycobacterial replication intracellularly, present the antigen at the site of infection during lymphocyte activation and are liable to eliminate the internalized bacilli \[[@R35]\]. The ligand-gated cation channel of the P2X7 receptor is highly expressed on macrophages in both humans and mice which allows the phenomenon of Ca^2+^ influx and K^+^ efflux involved in apoptosis initiation and phospholipase D activation that promotes the fusion of phagosome and lysosome and thus leads to death of the mycobacterium \[[@R36], [@R37]\].

Earlier studies revealed that P2X7 deficient animals have reduction in the incidence and severity of TB compared with wild-type animals \[[@R38]\]. *M. tb* infected P2X7 mice have also shown greater *M. tb* burden in their lung tissues as compared to the infected wild-type mice \[[@R39]\]. Keeping aforesaid facts about the key role of P2X7 receptor in view, a number of studies have been conducted to evaluate the relationship between *P2X7* 1513 A\>C gene polymorphism and the development of EPTB. The results from these published studies are contradictory and, therefore, inconclusive which prompted us to do the meta-analysis to improve the statistical power of this association. This meta-analysis to assess the association between *P2X7* 1513 A\>C polymorphism and EPTB risk was done from eight case-control studies, as combining of the data from different studies has an advantage of reducing the random error \[[@R40]\].

In this pooled study, we found that out of five types of genetic model comparisons, four genetic models of *P2X7* 1513 A\>C polymorphism showed association with increased risk of EPTB (when compared to wild type alleles and genotypes). Furthermore, when stratified the different ethnicities (Asian and Caucasian), a significant association of homozygous variant and heterozygous genotype was found with EPTB in Asian population. In Caucasian stratification, heterozygous and dominant models showed significant increased risk of EPTB when compared with wild type genotype.

The homozygous subjects of *P2X7* 1513 A\>C polymorphism found on exon 13 of *P2X7* gene showed reduced ATP

induced apoptosis and ATP mediated killing of mycobacteria, whereas heterozygous subjects showed significantly impaired ATP responsiveness \[[@R41], [@R42]\]. Previous meta-analysis conducted by Wu *et al.* \[[@R43]\] also reported significant association of *P2X7* 1513 A\>C polymorphism with EPTB risk, but they missed some of the pertinent studies due to limited database selection, as the research article existing in one database is not essentially available in another one. So, every meta-analysis has a major limitation of database selection and, additionally, some relevant studies might publish in other languages. Therefore, conducting this meta-analysis was necessary to derive a more robust conclusion. Comparatively, this study has major improvement(s) over previous one as in this meta-analysis we searched most famous and reliable databases i.e., Pubmed and EMBASE, and tried to increase the number of individuals as well as incorporate new reports in addition to the missing studies which were not taken into consideration in the previous meta-analysis.

As we know that the nature of genetic susceptibility to TB is polygenic \[[@R43]\]; hence, single genetic variants cannot be interpreted as adequate for the risk of this dreaded disease. The important aspect of this gene polymorphism is that its occurrence can vary sufficiently among different races or ethnic populations. Prior to reaching a conclusion, limitations of the present meta-analysis must be discussed. Firstly, we found heterogeneity in this study, which might be attributed to one or multiple reasons from the following, (a) the ethnicity of the patients, (b) recruiting control samples - ethnicity specific genetic variations may influence host immunity to TB, causing different TB susceptibilities \[[@R44]\]. Second, studies published only in English language were included. The third limitation is database selection, the studies indexed by the selected electronic databases (PubMed, EMBASE) were included for this analysis. There is a possibility that some relevant articles might have been published in other languages and indexed with other databases (not known to us) which we may have missed. The fourth limitation is that due to lack of sufficient information in the primary reports, the data was not stratified by other factors such as HIV status and TB severity.

Despite these limitations, there are some advantages as well associated with this meta-analysis. First, this meta-analysis incorporated more studies than the earlier published researches making this to be more balanced and robust. Second, the subgroup analysis was also done and found that *P2X7* 1513 A\>C polymorphism have more likelihood to develop EPTB in Asian and Caucasian population.

CONCLUSION
==========

In conclusion, the present meta-analysis shows significant association of *P2X7* 1513 A\>C polymorphism with genetic susceptibility to overall EPTB risk. Separate subgroup analysis of both Asian and Caucasian populations also showed association of *P2X7* 1513 A\>C polymorphism with risk of developing EPTB. However, future large well-designed studies which include more EPTB cases and healthy controls might be helpful to provide more precise conclusion and further validation of our results. Also, larger studies will help in understanding the role of *P2X7* 1513 A\>C polymorphism in the pathophysiology of EPTB.
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![**a).** Forest plot for overall analysis (C vs. A, AC vs. AA, CC vs. AA) showing OR with 95% CI to evaluate the association of the *P2X7* A1513C (rs 3751143) gene polymorphism and EPTB risk.](CG-17-450_F3a){#F3a}
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![**a).** Forest plot for Caucasian population (C vs. A, AC vs. AA, CC vs. AA) showing OR with 95% CI to evaluate the association of the *P2X7* A1513C (rs 3751143) gene polymorphism and EPTB risk.](CG-17-450_F5a){#F5a}

![Forest plot for Caucasian population (CC + AC vs. AA, CC vs. AA + AC) showing OR with 95% CI to evaluate the association of the *P2X7* A1513C (rs 3751143) gene polymorphism and EPTB risk.](CG-17-450_F5b){#F5b}

###### Main characteristics of all the studies summarized for the present meta-analysis.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **First Authors and**\          **Year**   **Country of Origin**               **Ethnicity**   **Genotyping Method**   **Cases**   **Controls**   **Source of**\
  **Reference No.**                                                                                                                                 **Genotyping**
  ------------------------------- ---------- ----------------------------------- --------------- ----------------------- ----------- -------------- ----------------
  Fernando *et al.* \[[@R18]\]    2007       Southeast Asia (Liverpool cohort)   Asian           ABI PRISM               30          167            Blood

  Fernando *et al.* \[[@R18]\]    2007       Australia                           Caucasian       ABI PRISM               50          102            Blood

  Xiao *et al.* \[[@R19]\]        2009       China                               Asian           PCR-RFLP                55          384            Blood

  Taype *et al.* \[[@R20]\]       2010       Peru                                Caucasian       PCR-RFLP                121         513            Blood

  Tekin *et al.* \[[@R21]\]       2010       Turkey                              Caucasian       PCR-RFLP                100         192            Blood

  Sharma *et al.* \[[@R22]\]      2010       India                               Asian           PCR-RFLP                23          177            Blood

  Ben-Selma *et al.* \[[@R23]\]   2011       Tunisia                             Caucasian       PCR-RFLP                55          150            Blood

  Singla *et al.* \[[@R24]\]      2012       India                               Asian           PCR-RFLP                71          392            Blood

  Ozdemir *et al.* \[[@R25]\]     2014       Turkey                              Caucasian       PCR-RFLP                89          160            Blood
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### Distribution of *P2X7* A1513C gene polymorphism studies included in this meta-analysis.

  **Authors, Year of Publication and Reference No.**   **Ethnicity**   **Controls**   **Cases**   **HWE**                                
  ---------------------------------------------------- --------------- -------------- ----------- --------- ------ ---- ---- ---- ------ -------
  Fernando *et al.* 2007 \[[@R18]\]                    Asian           105            55          7         0.20   9    17   4    0.41   0.950
  Fernando *et al.* 2007 \[[@R18]\]                    Caucasian       64             34          4         0.20   18   28   4    0.36   0.840
  Xiao *et al.* 2009 \[[@R19]\]                        Asian           221            119         44        0.26   30   19   6    0.28   0.001
  Taype *et al.* 2010 \[[@R20]\]                       Caucasian       347            149         17        0.17   82   37   2    0.16   0.830
  Tekin *et al.* 2010 \[[@R21]\]                       Caucasian       141            46          5         0.14   39   28   7    0.28   0.590
  Sharma *et al.* 2010 \[[@R22]\]                      Asian           126            48          3         0.15   8    13   2    0.36   0.510
  Ben-Selma *et al.* 2011 \[[@R23]\]                   Caucasian       104            40          6         0.17   19   23   13   0.44   0.340
  Singla *et al.* 2012 \[[@R24]\]                      Asian           258            123         11        0.18   45   22   1    0.17   0.410
  Ozdemir *et al.* 2014 \[[@R25]\]                     Caucasian       76             63          21        0.32   47   34   8    0.28   0.170

HWE: Hardy-Weinberg equilibrium.

###### Statistics to test publication bias and heterogeneity for overall analysis.

  **Comparisons**   **Egger's Regression Analysis**   **Heterogeneity Analysis**   **Model Used for the Meta-analysis**                           
  ----------------- --------------------------------- ---------------------------- -------------------------------------- ------- ------- ------- --------
  C vs A            10.47                             1.26 to 19.69                0.031                                  50.83   0.001   84.26   Random
  CC vs AA          1.76                              -4.49 to 8.02                0.520                                  32.63   0.001   75.48   Random
  AC vs AA          6.46                              2.73 to 10.19                0.001                                  26.36   0.001   69.65   Random
  CC+AC vs AA       7.70                              2.59 to 12.80                0.009                                  39.66   0.001   79.83   Random
  CC vs AA+AC       0.88                              -4.40 to 6.18                0.700                                  23.06   0.001   65.31   Random

###### Statistics to test publication bias and heterogeneity of asian population.

  **Comparisons**   **Egger's Regression Analysis**   **Heterogeneity Analysis**   **Model Used for the Meta-analysis**                           
  ----------------- --------------------------------- ---------------------------- -------------------------------------- ------- ------- ------- --------
  C vs A            12.02                             -1.02 to 25.06               0.050                                  15.32   0.002   80.42   Random
  CC vs AA          1.89                              -11.59 to 15.38              0.600                                  9.37    0.025   67.98   Fixed
  AC vs AA          7.59                              5.44 to 9.73                 0.001                                  10.94   0.012   72.59   Fixed
  CC+AC vs AA       8.46                              6.52 to 10.39                0.002                                  14.05   0.003   78.69   Random
  CC vs AA+AC       1.17                              -9.52 to 11.86               0.680                                  5.58    0.130   46.31   Fixed

###### Statistics to test publication bias and heterogeneity of caucasian population.

  **Comparisons**   **Egger's Regression Analysis**   **Heterogeneity Analysis**   **Model Used for the Meta-analysis**                           
  ----------------- --------------------------------- ---------------------------- -------------------------------------- ------- ------- ------- --------
  C vs A            17.23                             -5.29 to 39.76               0.090                                  35.49   0.001   88.73   Random
  CC vs AA          2.00                              -17.96 to 21.99              0.770                                  23.20   0.001   82.76   Random
  AC vs AA          7.60                              -1.73 to 16.95               0.080                                  15.37   0.004   73.99   Random
  CC+AC vs AA       10.33                             -2.76 to 23.42               0.080                                  25.58   0.001   84.36   Random
  CC vs AA+AC       0.74                              -16.01 to 17.50              0.890                                  17.34   0.002   76.93   Random
